FindTrial
Sign In

Validaion of Node Reporting and Data System 1.0 (Node-RADS) in head and neck tumors

Validaion of Node Reporting and Data System 1.0 (Node-RADS) in head cand neck tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073626
Enrollment
Unknown
Registered
2023-07-17
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck tumor

Interventions

Gold Standard:histological results, the response of the lesion to treatment
Index test:Node-RADS score

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Pathological diagnosis of head and neck tumor (including nasopharyngeal carcinoma) Contrast-enhanced CT or MRI before treatment The extent of lymph node dissection and postoperative pathology should be clarified in patients undergoing radical surgery Patients receiving concurrent chemoradiotherapy (including induction chemotherapy) without surgery should have the same modality imaging data before and after treatment

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Node-RADS score;sensitivity;specificity;—

Countries

China

Contacts

Public ContactXuelei Ma

Division of Biotherapy, Cancer Center, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, No. 37 GuoXue Alley, Chengdu 610041, China

drmaxuelei@gmail.com+86 134 0841 0416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026